Joseph Truitt

Director

Mr. Truitt currently serves as President and CEO of Achillion and joined the Board of Directors in May 2018. Mr. Truitt began his tenure at Achillion in 2009 as Vice President of Business Development and Chief Commercial Officer. Prior to Achillion, Mr. Truitt was Vice President of Business Development and Product Strategy at Lev Pharmaceuticals, before its acquisition by Viropharma, Inc.